Myocardial Revascularization in COVID-19 Era

Sasmojo Widito


Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). More discussion is required to achieve the balance between clinical benefit and risk in the treatment of acute coronary syndrome (ACS) patients with COVID-19. The current COVID-19 pandemic prompts the need to evaluate criteria for indication and efficacy of the general safety protocols and particular cardiac catheterization laboratory (CCL) procedures to safeguard the patient and healthcare professionals


myocardial revascularization, COVID-19 era

Full Text:



Welt, F., Shah, P., Aronow, H., Bortnick, A., Henry, T., Sherwood, M., Young, M., Davidson, L., Kadavath, S., Mahmud, E. and Kirtane, A., 2020. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic. Journal of the American College of Cardiology, 75(18), pp.2372-2375.

Martinez Sara. 2020. The Cardiology Cath Lab in the COVID-19 Era. Cardiac Interventions Today,vol. 14:4

Szerlip et al, 2020. Considerations for cardiac catheterization laboratory procedures during the COVID ‐19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates. Catheterization and Cardiovascular Interventions, 96(3), pp.586-597.

Mariano, G., Lemke, V., Paiva, M. and Oliveira, G., 2020. Covid-19 and Safety in the Cath Lab: Where We Are and Where We Are Headed. International Journal of Cardiovascular Sciences, 33(3), pp.288-294.

European Society of Cardiology. 2020. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic

Ibanez B et al. 2018. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Roffi M et al. 2016. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Knuuti, J. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 41(3), pp.407-477.

Li, Y., Wang, M., Huang, W. and Hwang, J., 2021. Management of acute coronary syndrome in patients with suspected or confirmed coronavirus disease 2019: Consensus from Taiwan Society of Cardiology. Journal of the Formosan Medical Association, 120(1), pp.78-82.

Hauguel-Moreau et al. 2020. Impact of Coronavirus Disease 2019 outbreak on acute coronary syndrome admissions: four weeks to reverse the trend. Journal of Thrombosis and Thrombolysis, 51(1), pp.31-32.



  • There are currently no refbacks.

Copyright (c) 2021 Sasmojo Widito

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.